SUBJECT: Medicine 2 DATE: July 02, 2008 TOPIC: Fever of Undetermined Origin LECTURER: Mr. Alberto Gabriel TRANSGROUP:SMV DEFINITION
Classic definition by Petersdorf &Beeson, 1961 An illness that is characterized by a temperature of 38.3°C or greater on multiple occasions that lasts three weeks or longer, and that remains undiagnosed after one week of in-hospital evaluation. • Durack & Street, 1991 Proposed a new system of classification of FUO * (-) for any laboratory results
COMMON CAUSES OF CLASSIC FUO Table 2. Causes of FUO in Adults Petersd orf & Beeson (1961) 100 cases 36
Category
Table 1. Modifications of FUO definition by Durack & Street, 1991 IMMUNODEFICIENT NEUTROPEN IC
HIV – ASSOCIAT ED
NOSOCOMIA L
Patients not in other categories fever ≥ 3 weeks
Has < 500 neutrophils
Confirmed HIV positive
Hospitalized , Acute case, No infection when admitted
3 days or 3 OPD visits
3 days
CLASSIC
Patient type Duration of illness while under investigati on
Example of etiology
Infections, malignanci es, inflammato ry disease
Perianal infection, aspergillosis , candidemia
3 days or 4 weeks as OPD
3 days
MAI, TB, nonHodgkin’s lymphoma
Septic thrombophlebitis, sinusitis, C. difficile colitis
Infections
Larson, Featherslone & Petersdorf (1982) 105 cases
Knockaert Vanneste & Babbaers (1992) 187 cases
Klejin (1997) 167 cases
31
23
26
Malignancy Collagenvascular disease
19
31
7
12.5
15
9
22
24
Others
23
7
23
8
Undiagnosed
7
12
25
30
*Naproxen – treatment for rheumatic fever - test after 3 days = (-) fever → not infectious (+) fever → infectious Table 3. Causes of FUO in Children
CATEGORIES Diagnostic Categories of FUO • Infections – most common cause classical FUO Systemic Localized • Neoplasms • Collagen-vascular disease Inflammatory diseases CTD, autoimmune diseases • Miscellaneous causes Drug fever Pulmonary embolism Factitious fever • Undiagnosed
of
Category
Pizzo, et al. (1972) 100 cases
Lohr & Hendley (1974) 84 cases
Mc Chung (1980) 99 cases
Infections
82
33
29
Malignancy
20
18
11
Collagen-vascular disease
6
13
8
Miscellaneous
10
15
19
Undiagnosed
12
19
32
Table 4. Local Experience (PGH, 1975-1990), unpublished
Infections Malignancy Collagen-vascular (autoimmune) Hypersensitivity Unknown Total
Number (%) 34 (46.6) 20 (27.4) 10 (13.7) 2 (2.7) 7 (9.6) 73 (100)
Source: M.F. Mendoza MD, 29th PSMID Conv Table 5. Diagnostic Categories of 72 Patients with FUO at the Santo Tomas University Hospital
Infections Neoplasms Connective tissue disease Miscellaneous Unknown INFECTIONS 1. TB 2. Abdominal abscess 3. Cryptic abscess 4. Typhoid fever
Number (%) 44 (61) 9 (13) 4 (6) 3 (4) 12 (17)
Page5
•
MA RY YVE TTE ALL AIN TIN A RAP LH SHE RYL BAR T HEI NRI CH PIP OY KC JAM CEC ILLE DEN ESS E VIN CE HO OPS CES XTI AN LAI NEY RIZ KIX EZR A GOL DIE BUF F MO NA AM MA AN ADI KC PEN G KAR LA ALP HE AAR ON KYT H AN NE EIS A KRI NG CAN DY ISA Y MA RCO JOS HU A FAR S RAI N JAS SIE MIK A SHA
SUBJECT: Medicine 2 DATE: July 02, 2008 TOPIC: Fever of Undetermined Origin LECTURER: Mr. Alberto Gabriel TRANSGROUP:SMV
-
Chronic active hepatitis Infective endocarditis Leptospirosis Pyelonephritis Malaria Chronis sinusitis Toxoplasmosis Osteomyelitis
Predominant cause in developing countries High in infants and children Vary according to place (country) Ex. Visceral Leishmaniasis – Middle East Melioidosis – South East Asia & Australia K Fujimoto Disease – Japan - Cervical lymphadenopathy - Malaise - Fever
PARASITIC INFECTIONS AS CAUSE OF FUO - may occur with other concomitant cause • Schistosoma • Leishmaniasis • Toxoplasmosis • Others – Fasciola, Amoeba MALIGNANCIES & FUO • Hematologic and solid tumors: Lymphoma Acute leukemia (children) Hypernephroma (Renal cell CA) Bone sarcoma Atrial myxoma GI – gastric CA, liver, colon MALIGNANCY (Neoplasms) • Frequency decreasing • Higher in elderly • More in developed country • Infection is secondary COLLAGEN-VASCULAR DISEASE (Autoimmune)
• • • • • •
Systemic Lupus Erythematosus Rheumatoid arthritis Systemic vasculitis Mixed connective tissue disease Rheumatic fever (most common due to presence of Streptococcus pneumoniae/viridans → heart valves, kidney) Others e.g. Still’s disease
CONNECTIVE TISSUE DISEASE • Young adults –SLE • Still’s disease (JRA) • Elderly – Temporal arteritis and Polymyalgia rheumatica • More in developed countries
MISCELLANEOUS CAUSES • Pulmonary embolism • Chronic hepatitis • Other granulomatous diseases • CNS causes • Cyclic neutropenia • Factitious fever • GHVD HYPERSENSITIVITY DISEASES • Drug fever
• • • • • •
Erythema multiforme – skin infection Allergic vasculitis Serum sickness Milk allergy Halothane sensitization Post-pericardiotomy syndrome
AGENTS COMMONLY ASSOCIATED WITH DRUGINDUCED FEVER • Allopurinol (Zyloprim) • Captopril (Capoten) • Cimetidine (Tagamet) • Clofibrate (Atromid-S) • Erythromycin • Heparin • Hydralazine (Apresoline) • Hydrochlorothiazide (Esidrix) • Isoniazid • Meperidine (Demerol) • Methyldopa (Aldomet) • Nifedipine (Procardia) • Nitrofurantoin (Furadantin) • Penicillin • Phenytoin (Dilantin) • Procainamide (Pronestyl) • Quinidine HIV-RELATED FUO • Opportunistic infections Atypical manifestations Prior antibiotic prophylaxis • Mycobacterial infection – most common in the Philippines • Collagen-vascular – uncommon • Pneumonia – other countries NOSOCOMIAL FUO • > 48 hours in hospital or at least 3 days before the start of fever • Risk factors Urinary & respiratory instrumentation Surgery IV devices Drugs Immobilization
Page5
5. 6. 7. 8. 9. 10. 11. 12.
SUBJECT: Medicine 2 DATE: July 02, 2008 TOPIC: Fever of Undetermined Origin LECTURER: Mr. Alberto Gabriel TRANSGROUP:SMV -
Fracture pelvis) ICU
in
sensitive
areas
(thigh,
IMMUNODEFICIENT FUO A. Immunosuppression Infection Atypical manifestation GVHD in transplants B. Neutropenic Bacteremia & sepsis Fungal infection
2.
Blood or BMA C/S - 3 aerobic and anaerobic in the 1st 2 days of hospitalization 3. PPD test 4. Subsequent tests must be individualized C. Use of specific test 1. Autoantibody screening 2. Specific PCR 3. Imaging X-ray Isotope scanning 4. Tumor markers * TB – cause of prolong fever
COMMON APPROACH TO FUO
Evaluation of FUO Starts with very good history and PE 1. History – documented fever Recent travel Exposure to pets/animals Work environment Family history Medication 2. PE – subtle signs and symptoms Nausea Aaaa Oral ulcers Fundoscopy Petechial/splinter hemorrhages
USEFUL LABORATORY EXAMINATIONS
DIAGNOSIS • More aggressive and rapid evaluation for critically ill patients – as soon as possible • Evaluation slow and deliberate (out-patient) for the chronically ill EVALUATION OF A PATIENT WITH FUO A. No obvious cause, systemic symptoms not disabling OPD work-ups CBC with ESR Urinalysis Chest x-ray Alkaline phosphatase, SGOT ANA, other serologic tests Blood culture Stool for guiac B. Persistence of fever or clinical deterioration – hospitalization 1. Repeat tests done in OP setting
DIAGNOSTIC ADVANCES • Ultrasonography • Echocardiography • CT scan • Magnetic Resonance Imaging (MRI) – identify which part is affected
• • • • •
Labelled WBC – Indium, Technetium Gallium scan Angiography PET scan Venous duplex imaging of LE
Table 6. Diagnostic Categories of 72 Patients with FUO at the Santo Tomas University Hospital Tuberculosis, malignancy, Chest radiograph Pneumocystis carinii pneumonia CT of abdomen or pelvis with Abscess, malignancy contrast agent Gallium 67 scan Infection, malignancy Indium-labeled leukocytes Occult septicaemia Acute infection and Technetium Tc 99m inflammation of bones and soft tissue Malignancy, autoimmune MRI of brain conditions PET scan Malignancy, inflammation Transthoracic or transesophageal Bacterial endocarditis echocardiography Venous Doppler study Venous thrombosis
TUMOR MARKERS
• •
•
Diagnostic α feto protein (AFP) β HCG Highly supportive C19-9 CA125 CEA PSA Others
NON SPECIFIC INFLAMMATORY MARKERS • Procalcitonin
Page5
FUO General Consideration 1. Well organized systemic approach 2. Age group difference 3. Duration of fever → > 3 weeks 4. Type of hospital 5. Immune state/underlying diseases DM, collagen problem
SUBJECT: Medicine 2 DATE: July 02, 2008 TOPIC: Fever of Undetermined Origin LECTURER: Mr. Alberto Gabriel TRANSGROUP:SMV
•
Specific at high titers but not sensitive C-reactive protein Positive for bacterial infections ESR – sensitivity 53%, Low ESR helpful to r/o bacteremia >80-100 mm/hr useful aid and clinical marker of disease activity for CTD
INVASIVE DIAGNOSTIC PROCEDURES A. Tissue diagnosis (Biopsy) 1. Liver 2. Bone marrow 3. Lymph node 4. Skin nodule/rash and muscle 5. Temporal artery B. Angiography C. Explratory laparotomy Table 7. The Value of Exploratory Laparotomy in FUO
Operative findings in 70 FUO cases Number (%) Malignant 21 (30.0) Specific infection 21 (21.4) Indeterminate disease 14 (20.0) Miscellaneous 6 (8.6) Nothing found 14 (20.0) Source: Mayo clinic ESR • • • •
Liver and bone marrow biopsy
SELECTED CAUSES OF FUO (Mandell) • Disseminated granulomatosis • Lymphoma • Thromboembolic disease • Endocarditis • Adult Still’s disease • Drug fever • Temporal arteritis and PMR
EVALUATION OF A PATIENT WITH FUO REQUIRES: • Knowledge of those disorders that produce this syndrome (FUO) • Recognition of the potential significance of subtle findings in the history and physical examination • Awareness of the value in the clinical setting of specific diagnostic procedures
NOSOCOMIAL INFECTION
Sensitivity 53% Specificity 33% (-) PPV for bacteremia 94% ↓ ESR (<20 mm/hr) helpful to r/o bacteremia
DIAGNOSIS OF FEVER OF UNKNOWN ORIGIN * see last page
EMPIRIC TREATMENT
TREATMENT AND MANAGEMENT • Non-specific treatment is rarely curative and may delay diagnosis • NSAIDS – Ibuprofen, Indomethacin, Naproxen
• •
EMPIRIC STEROIDS • Seldom indicated • Consider cryptic TB Difficult to exclude
Response to ASA & NSAIDS – may mask fever of infection Naproxen test Therapeutic trial
THERAPEUTIC TRIAL • Specific therapy – specific goal and hypothesis • Time limit • Regular, reliable observation of vital signs and clinical conditions • Use drugs with limited spectrum • May delay diagnosis • Only for seriously ill patients – nosocomial FUO, febrile neutropenia • Some FUO may resolve spontaneously
DEFINITION Nosocomial infection – are infectious which are the result of treatment in a hospital or a healthcare service unit. they appear as fever after 48 hours or more after hospital admission or within 30 days after discharge Other known as: “Hospital-acquired infection” “Healthcare-associated infection” COMMON CAUSES • Urinary tract infection • Surgical sites • Pneumonias TRANSMISSION • Contact (direct or indirect) transmission • Droplet transmission • Airborne transmission • Common vehicle-borne transmission • Vector-borne transmission PREDISPOSITION INFECTION • Host factors – poor state of health, advanced age, prematurity, immunodeficiency • Invasive devices – intubation tubes, catheters, surgical drains • Host treatments – immunosuppressive, antimicrobials or recurrent blood transfusion
Page5
•
SUBJECT: Medicine 2 DATE: July 02, 2008 TOPIC: Fever of Undetermined Origin LECTURER: Mr. Alberto Gabriel TRANSGROUP:SMV
PREVENTION • Isolation • Handwashing and gloving • Aprons • Masks
DIAGNOSIS OF FEVER OF UNKNOWN ORIGIN Complete history and physical assessment Positive findings
No CBC, electrolytes, LFT, blood culture, urinalysis, urine culture, ESR, PPD skin test, chest radiograph Positive results
No
CT of abdomen/pelvic with contrast
Page5
Assign to most likely category
SUBJECT: Medicine 2 DATE: July 02, 2008 TOPIC: Fever of Undetermined Origin LECTURER: Mr. Alberto Gabriel TRANSGROUP:SMV
No
Lumbar puncture, gallium 67 scan, sinus films (radiography or CI)
Autoimmune conditions Rheumatoid factor, ANA
Malignancie
Hematologic Peripheral smear, serum protein electrophoresis Diagnosis clear ?
NonHematologic Mammography, chest CT with contrast, upper/lower endoscopy, bone scan, gallium 67 scan
No
Miscellaneous Order appropriate diagnostic tests based on information from the history
Temporal artery biopsy, lymph node biopsy
No No Bone marrow MRI of the brain, biopsy of suspicious skin lesions or lymph nodes, liver biopsy, diagnostic laparoscopy
Page5
Infection Urine and sputum cultures for AFB, VDRL, HIV test; serology for CMV, EBV, ASO titer (geographically specific testing)